Stemcentrx
Develops innovative therapies for cancer.
Employees
Enterprise value
$10.2b
| Date | Investors | Amount | Round |
|---|---|---|---|
$23.5m | Late VC | ||
$42.0m | Series D | ||
$200m | Series F | ||
$250m | Series G | ||
$10.2b Valuation: $10.2b | Acquisition | ||
| Total Funding | $515m | ||
Fidelity Investments(exited)
Founders Fund(exited)
Silicon Valley Bank(exited)
Sequoia(exited)
Capital Group(exited)
James Hong(exited)
Artis Ventures(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.